Skip to content

Tag: Bayer

Explore our medication guides and pharmacology articles within this category.

What is Zam-Buk? A Look at the History and Uses of the Antiseptic Ointment

4 min read
First sold in 1902 in England, the traditional herbal balm and antiseptic ointment **Zam-Buk** has been a household staple for over a century and remains particularly popular in South Africa, Australia, and parts of Asia. Known for its distinctive green color and powerful, soothing aroma, this topical remedy is used for a variety of minor skin conditions, from cuts and scrapes to insect bites and bruises.

The Pharmaceutical Saga: A Look at Where Did Suramin Come From?

4 min read
First synthesized by chemists at Bayer AG in 1916, suramin originated from early medicinal chemistry research into antiparasitic dyes. This discovery set off a fascinating story of scientific innovation, political intrigue, and a secret formula, answering the question of where did suramin come from.

What is the relationship between salicylic acid and aspirin?

4 min read
An estimated 40,000 tonnes of aspirin are consumed annually worldwide [1.4.6]. The key to this ubiquitous drug lies in its origin. So, what is the relationship between salicylic acid and aspirin? Aspirin is the acetylated derivative of salicylic acid, created through a chemical synthesis process called esterification [1.2.1, 1.2.6].

Is aspirin a salicylate acid? Exploring the Chemical Relationship

2 min read
Medications containing salicylates have been used for centuries, but modern aspirin is not salicylic acid itself; it's a synthetic derivative. Understanding this key chemical distinction is fundamental to comprehending how this common drug functions and the history behind its development. The short answer to 'Is aspirin a salicylate acid?' is no, but its deep chemical connection is undeniable.

Who Makes Riociguat? The Pharmaceutical Companies Behind Adempas

4 min read
Originally developed by Bayer Healthcare Pharmaceuticals, the medication riociguat (brand name Adempas) is now part of a global collaboration involving both Bayer and Merck (known as MSD outside the US). This partnership governs the development and commercialization of this important treatment for specific forms of pulmonary hypertension.

How Does Kogenate Work? A Deep Dive into Recombinant Factor VIII for Hemophilia A

3 min read
Hemophilia A is a genetic bleeding disorder that affects approximately 1 in 5,000 male births and is caused by a deficiency of clotting factor VIII. The medication **Kogenate**, a brand of recombinant Factor VIII, works by temporarily replacing this missing protein, restoring the blood's ability to clot effectively and enabling the control and prevention of bleeds.